trapidil has been researched along with probucol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Katsenovich, ER; Khorets, BA; Mazurov, AV; Rainkina, TV | 1 |
| Scheffold, T; Tost, B; von Hodenberg, E | 1 |
| Ishiwata, S; Kitai, T; Yamaguchi, T | 1 |
| Douglas, JS | 1 |
2 review(s) available for trapidil and probucol
| Article | Year |
|---|---|
[Prevention of postangioplasty restenosis].
Topics: Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Humans; ortho-Aminobenzoates; Paclitaxel; Probucol; Radiotherapy; Sirolimus; Stents; Trapidil | 2003 |
Pharmacologic approaches to restenosis prevention.
Topics: Angioplasty, Balloon, Coronary; Cilostazol; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Humans; ortho-Aminobenzoates; Pioglitazone; Platelet Aggregation Inhibitors; Probucol; Risk Factors; Stents; Tetrazoles; Thiazolidinediones; Trapidil; Treatment Outcome | 2007 |
4 other study(ies) available for trapidil and probucol
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[The radioisotope labelling of thrombocytes using a monoclonal antibody against membrane glycoproteins IIb-IIIa and the measurement of thrombocyte adhesion/aggregation on the substrate surface].
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Blood Platelets; Chromium Radioisotopes; Drug Interactions; Humans; Iodine Radioisotopes; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Platelet Membrane Glycoproteins; Probucol; Prostaglandin Endoperoxides, Synthetic; Radionuclide Imaging; Surface Properties; Trapidil | 1992 |
[New strategies in the treatment of restenosis].
Topics: Angioplasty, Balloon, Coronary; Angioplasty, Balloon, Laser-Assisted; Anticholesteremic Agents; Atherectomy; Brachytherapy; Coronary Disease; Genetic Therapy; Humans; Platelet Aggregation Inhibitors; Probucol; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stents; Time Factors; Trapidil; Vasodilator Agents; Verapamil | 2000 |